MERIDIAN BIOSCIENCE INC's ticker is VIVO and the CUSIP is 589584101. A total of 181 filers reported holding MERIDIAN BIOSCIENCE INC in Q4 2021. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $402,937 | -32.7% | 12,133 | -36.2% | 0.00% | -100.0% |
| Q3 2022 | $599,000 | +56.4% | 19,008 | +50.9% | 0.00% | – |
| Q2 2022 | $383,000 | +28.5% | 12,594 | +9.5% | 0.00% | – |
| Q1 2022 | $298,000 | +22.1% | 11,497 | -3.9% | 0.00% | – |
| Q4 2021 | $244,000 | -45.3% | 11,968 | -48.3% | 0.00% | – |
| Q3 2021 | $446,000 | -74.0% | 23,166 | -70.0% | 0.00% | -100.0% |
| Q2 2021 | $1,715,000 | -26.9% | 77,329 | -13.5% | 0.00% | 0.0% |
| Q1 2021 | $2,346,000 | +31.0% | 89,388 | -6.7% | 0.00% | 0.0% |
| Q4 2020 | $1,791,000 | +16.6% | 95,853 | +5.9% | 0.00% | 0.0% |
| Q3 2020 | $1,536,000 | -39.8% | 90,486 | -17.4% | 0.00% | -33.3% |
| Q2 2020 | $2,552,000 | +213.5% | 109,592 | +13.1% | 0.00% | +200.0% |
| Q1 2020 | $814,000 | +236.4% | 96,856 | +583.7% | 0.00% | 0.0% |
| Q3 2015 | $242,000 | -62.6% | 14,167 | -52.9% | 0.00% | -83.3% |
| Q2 2013 | $647,000 | – | 30,096 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Technologies Management, LLC | 115,571 | $3,034,000 | 2.64% |
| Acuitas Investments, LLC | 160,046 | $4,201,000 | 2.41% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 144,000 | $3,780,000 | 0.78% |
| GLOBEFLEX CAPITAL L P | 158,664 | $4,165,000 | 0.76% |
| CLARK ESTATES INC/NY | 220,000 | $5,775,000 | 0.74% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 721,176 | $18,931,000 | 0.69% |
| EARNEST PARTNERS LLC | 4,341,834 | $113,973,000 | 0.68% |
| MOODY ALDRICH PARTNERS LLC | 138,844 | $3,645,000 | 0.53% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 889,269 | $23,343,000 | 0.49% |
| Phocas Financial Corp. | 134,740 | $3,537,000 | 0.47% |